{"id":"756f4c26c01c","type":"article","url":"https://hartvaat.nl/2026/12/01/aha-acc-richtlijn-voor-sportdeelneming-extra-aandacht-voor-hypertensie-commotio-/","title":"AHA/ACC-richtlijn voor sportdeelneming: extra aandacht voor hypertensie, commotio cordis en extreme omstandigheden","title_en":"Task Force 11: Additional Cardiac Conditions and Considerations in Competitive Athletes.","category":"hypertensie","category_label":"Hypertensie","professions":["cardioloog"],"tags":[],"journal":"Medicine and science in sports and exercise","doi":"10.1249/MSS.0000000000004099","source_url":"https://doi.org/10.1249/MSS.0000000000004099","authors":["Jeffrey J Hsu","Aaron L Baggish","Katherine E Economy","Michael S Emery","Mark S Link","Tamanna Singh","Katie M Stewart","Benjamin D Levine","Jonathan H Kim","Andre Lagerche"],"significance":5,"published":"2026-11-21","source_date":"2026-12-01","image":"https://hartvaat.nl/global/img/6e2cc0469790.webp","kennis":["https://hartvaat.nl/kennis/hypertensie/nhg-standaard-cvr-2019/","https://hartvaat.nl/kennis/nierziekte/nierziekte-en-cardiovasculair-risico/"],"congress":"","summary_en":"The updated AHA/ACC scientific statement on cardiovascular considerations for competitive athletes includes Task Force 11, which addresses specific cardiac conditions not covered elsewhere. Key topics include hypertension, commotio cordis, pulmonary embolism, performance-enhancing substances, exercise in extreme environments, and pregnancy. The task force provides a structured clinical framework for evaluating and managing athletes with these conditions. This guidance offers practical recommendations for cardiologists and sports medicine physicians to optimize safety and reduce cardiovascular risk in competitive athletes.","created":"2026-11-15T02:00:09Z","updated":"2026-11-15T02:00:12Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"De AHA/ACC heeft een bijgewerkt wetenschappelijk statement gepubliceerd over cardiovasculaire screening en begeleiding van competitieve sporters. Task Force 11 behandelt specifieke aandoeningen die niet in de andere sectoren vallen, waaronder hypertensie, commotio cordis, longembolie, gebruik van prestatiebevorderende middelen, sporten in extreme omgevingen en zwangerschap. De taakgroep geeft een gestructureerd kader voor klinische evaluatie en risicomanagement bij deze patiëntgroepen. Voor cardiologen en sportartsen biedt dit statement praktische handvatten om veilig sporten te adviseren en acute cardiovasculaire risico’s te beperken.","abstract_original":"The recently updated AHA/ACC Scientific Statement: Clinical Considerations for Competitive Sports Participation for Athletes with Cardiovascular Abnormalities provides a comprehensive framework for guiding clinicians in the evaluation and management of competitive athletes. Divided into 11 Task Forces, it covers a broad range of cardiovascular diseases and clinical scenarios. Task Force 11 was devoted to cardiac conditions and considerations in athletes not included in the other Task Forces. Here, we present the detailed rationale for the clinical considerations covered in this section of the Scientific Statement. These topics include hypertension, commotio cordis, pulmonary embolism, performance-enhancing drugs and supplements, exercise in extreme environments (specifically altitude and scuba diving), and pregnancy."}